We need your help to make ASweetLife even better. Completing our short reader survey will take only a few minutes, and by doing so you will be entered in a raffle to win a $25 Amazon gift card.
The U.S. FDA's Endocrinologic and Metabolic Drugs Advisory Committee voted 13 to 1 to recommend that Afrezza (insulin human [rDNA origin]) Inhalation Powder be granted marketing approval by the FDA
n efforts to reach the ultimate goal of a world without T1D, JDRF has been a leader in driving encapsulation research forward.
March 25th is the 26th Annual American Diabetes Association Alert Day, a one-day “wake-up call” asking the American public to take the Diabetes Risk Test to find out if they are at risk for developing type 2 diabetes.
Abbott Diabetes Care has issued a recall for the FreeStyle Blood Glucose Meter and the FreeStyle Flash Blood Glucose Meter. The recall was issued after the company discovered that FreeStyle Flash® and FreeStyle® Blood Glucose Meters may produce mistakenly low blood glucose results when using...
To encourage people with diabetes to cook and bake at home, ASweetLife has partnered with Bob's Red Mill to bring you an exciting giveaway.
Enter now to win a package that include a pack of Almond Meal, Hazelnut Meal, Coconut Flour, Chia Seeds, Flaxseed Meal, Dried Blueberries (no sugar added) and a $25 Bob’s Red Mill Gift Card.
The FDA has issued a complete response letter to Boehringer Ingelheim and Eli Lilly for the New Drug Application (NDA) of the investigational sodium glucose co-transporter-2 (SGLT2) inhibitor empagliflozin.
The complete response letter referenced previously observed deficiencies at a Boehringer Ingelheim facility where empagliflozin will be manufactured.
You know Kerri Sparling as a diabetes advocate, international speaker, and blogger. Now she's an author, too. Check out her brand new book, Balancing Diabetes.
Medtronic has begun distribution of i-port Advance, the first device to combine an injection port and an inserter in one complete set. i-port Advance can be used for people on insulin injection therapy who want to administer insulin conveniently while eliminating the need to puncture the skin with each dose of medication. i-port Advance injection port is FDA approved...
The FDA has requested clinical trial data from the manufacturer of saxagliptin, Bristol-Myers Squibb and AstraZeneca, to investigate a possible association between use of the type 2 diabetes drug and heart failure.